Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies
{{output}}
Background: Real-world evidence (RWE) can complement clinical trials to inform health technology assessments (HTAs). This study examined the extent to which RWE is considered in HTAs of non-oncology orphan medicinal products across six agencies globally. Metho... ...
